The Citing articles tool gives a list of articles citing the current article. The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Comprehensive Stress Degradation Studies of Afoxolaner Drug Substance and Identification of Major Degradation Products Including its Degradation Pathways by LC–HRMS–MS and NMR
Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife
Kotaro Takano, Lachlan de Hayr, Scott Carver, Robert J. Harvey and Kate E. Mounsey International Journal for Parasitology: Drugs and Drug Resistance 21 97 (2023) https://doi.org/10.1016/j.ijpddr.2023.02.004
Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions
Andrei Daniel Mihalca, Georgiana Deak, Luciana Cătălina Panait, Ștefan Rabei and Frederic Beugnet Parasites & Vectors 15(1) (2022) https://doi.org/10.1186/s13071-022-05428-y
Current review of isoxazoline ectoparasiticides used in veterinary medicine
Xueying Zhou, Alexandra E. Hohman and Walter H. Hsu Journal of Veterinary Pharmacology and Therapeutics 45(1) 1 (2022) https://doi.org/10.1111/jvp.12959
A double-blinded placebo-controlled evaluation of adipose-derived mesenchymal stem cells in treatment of canine atopic dermatitis
Diagnosis and Therapeutic Management of Canine Demodicosis in Saurashtra Region of Gujarat
Chintan G. Satasiya, Arshi A. Vagh, Awinash K. Bilwal, Raghuvir H. Bhatt and Dixit K. Parasana Indian Journal of Veterinary Sciences & Biotechnology 18(4) 139 (2022) https://doi.org/10.48165/ijvsbt.18.4.29
Pesticides - Updates on Toxicity, Efficacy and Risk Assessment
Motunrayo Ganiyat Akande, Solomon Usman Abraham and Johnson Caleb Ogunnubi Pesticides - Updates on Toxicity, Efficacy and Risk Assessment (2022) https://doi.org/10.5772/intechopen.104630
Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
Protecting dogs and cats against the Australian paralysis tick, Ixodes holocyclus (Acari: Ixodidae): A review of the Australian acaricide registration process
Efficacy of afoxolaner (NexGard®) on the treatment of myiasis caused by the New World screwworm fly Cochliomyia hominivorax (Diptera: Calliphoridae) in naturally infested dogs
Andre A. Cutolo, Nadège Perier, Ingrid Menz, Patricia Thyssen, Fabiano O. Silva and Frederic Beugnet Veterinary Parasitology: Regional Studies and Reports 24 100569 (2021) https://doi.org/10.1016/j.vprsr.2021.100569
Insecticidal efficacy of afoxolaner against bedbugs, Cimex lectularius, when administered orally to dogs
Hyalomma anatolicum resistance against ivermectin and fipronil is associated with indiscriminate use of acaricides in southwestern Balochistan, Pakistan
Diagnosis and treatment of demodicosis in dogs and cats
Ralf S. Mueller, Wayne Rosenkrantz, Emmanuel Bensignor, Joanna Karaś‐Tęcza, Tara Paterson and Michael A. Shipstone Veterinary Dermatology 31(1) 4 (2020) https://doi.org/10.1111/vde.12806
The sensitivity of Demodex canis (Acari: Demodicidae) to the essential oil of Melaleuca alternifolia – an in vitro study
Rita de Cássia da Silva Machado Neves, Luciano Antunes Barros, Shihane Mohamad Costa Mendes, et al. Revista Brasileira de Parasitologia Veterinária 29(3) (2020) https://doi.org/10.1590/s1984-29612020059
Afoxolaner as a Treatment for a Novel Sarcoptes scabiei Infestation in a Juvenile Potbelly Pig
A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
Is there a correlation between canine adult‐onset demodicosis and other diseases?
Lisa Pinsenschaum, Don Heung Lam Chan, Linda Vogelnest, Karin Weber and Ralf S Mueller Veterinary Record 185(23) 729 (2019) https://doi.org/10.1136/vr.105388
First Report of the Use of Afoxolaner/Milbemycin Oxime in an African Pygmy Hedgehog (Atelerix Albiventris) With Demodicosis Caused by Demodex Canis Identified By Molecular Techniques
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe
Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany
Canine demodicosis: a retrospective study of a veterinary hospital population in California, USA (2000–2016)
Daniel G Bowden, Catherine A. Outerbridge, Marguerite B. Kissel, Jerome N. Baron and Stephen D. White Veterinary Dermatology 29(1) 19 (2018) https://doi.org/10.1111/vde.12484
Concurrent development of generalised demodicosis, dermatophytosis and meticillin‐resistant Staphylococcus pseudintermedius secondary to inappropriate treatment of atopic dermatitis in an adult dog
Afoxolaner and fluralaner treatment do not impact on cutaneous Demodex populations of healthy dogs
Christine M. Zewe, Laura Altet, Andrea T. H. Lam and Lluís Ferrer Veterinary Dermatology 28(5) 468 (2017) https://doi.org/10.1111/vde.12453
Uso do fluralaner no tratamento da demodicidose canina juvenil generalizada: relato de caso
J.A.B. Bezerra, I.R.S. Cardoso, R.T.G.A. Rodrigues and K.D. Filgueira Arquivo Brasileiro de Medicina Veterinária e Zootecnia 69(6) 1491 (2017) https://doi.org/10.1590/1678-4162-9586
Efficacy of afoxolaner in a clinical field study in dogs naturally infested withSarcoptes scabiei